Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00111 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Yulong Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Genecast Biotechnology Co, Ltd, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, DNA Methylation, Cell-Free Nucleic Acids, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Simultaneous profiling of cell-free DNA (cfDNA) methylation and fragmentation features to improve the performance of cfDNA-based cancer detection is technically challenging. We developed a method to comprehensively analyze multimodal cfDNA genomic features for more sensitive esophageal squamous cell carcinoma (ESCC) detection. MATERIALS AND METHODS Enzymatic conversion–mediated whole-methylome sequencing was applied to plasma cfDNA samples extracted from 168 patients with ESCC and 251 noncancer controls. ESCC characteristic cfDNA methylation, fragmentation, and copy number signatures were analyzed both across the genome and at accessible cis-regulatory DNA elements. To distinguish ESCC from noncancer samples, a first-layer classifier was developed for each feature type, the prediction results of which were incorporated to construct the second-layer ensemble model. RESULTS ESCC plasma genome displayed global hypomethylation, altered fragmentation size, and chromosomal copy number alteration. Methylation and fragmentation changes at cancer tissue–specific accessible cis-regulatory DNA elements were also observed in ESCC plasma. By integrating multimodal genomic features for ESCC detection, the ensemble model showed improved performance over individual modalities. In the training cohort with a specificity of 99.2%, the detection sensitivity was 81.0% for all stages and 70.0% for stage 0-II. Consistent performance was observed in the test cohort with a specificity of 98.4%, an all-stage sensitivity of 79.8%, and a stage 0-II sensitivity of 69.0%. The performance of the classifier was associated with the disease stage, irrespective of clinical covariates. CONCLUSION This study comprehensively profiles the epigenomic landscape of ESCC plasma and provides a novel noninvasive and sensitive ESCC detection approach with genome-scale multimodal analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genecast Biotechnology Co, Ltd, Wuxi, Jiangsu, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
- The Precision Medicine Centre, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
- State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
ORCID-Profile: Yulong Li, Bing Liu, Hechuan Yang, Shi Yan, Jingjing Li, Yanfang Liu, Enli Zhang, Ning Shen, Yu S Huang, Nan Wu
Zitieren
APA
Li, Y., Liu, B., Zhou, X., Yang, H., Han, T., Hong, Y., Wang, C., Huang, M., Yan, S., Li, S., Li, J., Liu, Y., Zhang, E., Ni, Y., Shen, N., Chen, W., Huang, Y. S., & Wu, N. (2024). Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection. JCO Precision Oncology. https://doi.org/10.1200/po.24.00111
Vancouver
Li Y, Liu B, Zhou X, Yang H, Han T, Hong Y, et al. Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection. JCO Precision Oncology. 2024. doi:10.1200/po.24.00111
BibTeX
@article{Li2024,
author = {Li, Yulong and Liu, Bing and Zhou, Xuantong and Yang, Hechuan and Han, Tiancheng and Hong, Yuanyuan and Wang, Ciran and Huang, Miao and Yan, Shi and Li, Shaolei and Li, Jingjing and Liu, Yanfang and Zhang, Enli and Ni, Yang and Shen, Ning and Chen, Weizhi and Huang, Yu S and Wu, Nan},
title = {Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00111}
}
EUVIMED